前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201802245485384923
整理番号：18A1362299
新規FA-GNR-SIBRAFナノ系を用いた黒色腫に対するBRAF/MEK/ERK経路相乗的光熱治療法を遮断するためのBRAFの標的遺伝子サイレンシング【JST・京大機械翻訳】
Targeted-gene silencing of BRAF to interrupt BRAF/MEK/ERK pathway synergized photothermal therapeutics for melanoma using a novel FA-GNR-siBRAF nanosystem
Zhang Yujuan
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Zhang Yujuan
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Zhang Yujuan
(Biomaterials Innovation Research Center, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, USA)
,
Zhan Xuelin
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Zhan Xuelin
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Peng Shanshan
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Peng Shanshan
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Peng Shanshan
(Department of Surgery, Pathology and Oncology, University of Western Ontario, London, Canada)
,
Cai Ying
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Cai Ying
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Zhang Yu Shrike
(Biomaterials Innovation Research Center, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, USA)
,
Liu Yanling
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Liu Yanling
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Wang Zhigang
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Wang Zhigang
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Yu Yanrong
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Yu Yanrong
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Wang Yifan
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Wang Yifan
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Shi Qiaofa
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Zeng Xiaoping
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Yuan Keng
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Yuan Keng
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Zhou Nanjin
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Zhou Nanjin
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Joshi Rakesh
(Department of Surgery, Pathology and Oncology, University of Western Ontario, London, Canada)
,
Zhang Meng
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Zhang Meng
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Zhang Meng
(Department of Surgery, Pathology and Oncology, University of Western Ontario, London, Canada)
,
Zhang Zhuxu
(Department of Surgery, Pathology and Oncology, University of Western Ontario, London, Canada)
,
Min Weiping
(Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China)
,
Min Weiping
(Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China)
,
Min Weiping
(Department of Surgery, Pathology and Oncology, University of Western Ontario, London, Canada)
資料名：
Nanomedicine: Nanotechnology, Biology, and Medicine
(Nanomedicine: Nanotechnology, Biology, and Medicine)
巻： 14 号： 5 ページ： 1679-1693 発行年： 2018年
JST資料番号： W3138A ISSN： 1549-9634 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： オランダ (NLD) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。